Author:
Kotiw Michael,Morgan Michael,Taylor Stephen M.,Shiels Ian A.
Reference38 articles.
1. 1. Baggio V , Ott F , Fischer RW , et al. Production of antibodies to canine IL-1β and canine TNF to assess the role of proinflammatory cytokines. Vet Immunol Immunopathol. 2005;107:27-39.
2. 2. Tartaglia LA , Goeddel DV. Tumor necrosis factor receptor signalling: a dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J Biol Chem. 1992;267:4304-4307.
3. 3. Aderka D , Englemann H , Maor Y , Brakebusch C , Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med. 1992;175:323-329.
4. 4. Mohler KM , Torrance DS , Smith CA , et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxaemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol. 1993;151:1548-1561.
5. 5. Ellerin T , Rubin IH , Weinblatt ME. Infections and anti-tumor necrosis factor α therapy. Arthritis Rheum. 2003;48:3013-3022.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献